The Efficacy and Safety of K-001 in the Treatment of Advanced Pancreatic Cancer
NCT04183478
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
K-001
OTHER:
placebo
Sponsor
RenJi Hospital